Comparison of laser in situ keratomileusis outcomes with the Nidek EC-5000 and LSX LaserSight excimer lasers.
To report the results of laser in situ keratomileusis (LASIK) for myopia with and without astigmatism using the Nidek EC-5000 and LaserSight LSX excimer laser systems. A retrospective analysis of refractive outcomes with each laser was conducted. Approximately 2,900 myopic and astigmatic treatments up to -10.00 D (spherical equivalent refraction) were analyzed using refractive outcomes analysis software. At 6 months postoperatively, 78% of patients treated with the Nidek EC-5000 laser and 53% of patients treated with the LaserSight LSX laser were within +/-0.50 D of the intended correction. A difference in safety, stability, and efficacy of LASIK was found that favored the Nidek EC-5000 excimer laser.